A double-blind, placebo-controlled, randomized trial to evaluate the safety and efficacy of cerebrolysin in patients with Acute ischaemic Stroke in Asia - CASTA

International Journal of Stroke

Volumn 4, Issue 5, 2009, Pages 406-412

  Hong, Z ^a   Moessler, H ^b   Bornstein, N ^c   Brainin, M ^d   Heiss, W D ^a,e  

^a FUDAN UNIVERSITY   (China)

^b EBEWE Neuro Pharma ^*  (Australia)

^c TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^d DANUBE UNIVERSITY KREMS   (Austria)

^e MAX PLANCK INSTITUTE FOR NEUROLOGICAL RESEARCH   (Germany)

Author keywords

Cerebrolysin; Clinical trial; Infarct progression; Ischaemic stroke; Multimodal action; Neuroplasticity

Indexed keywords

ACETYLSALICYLIC ACID; CEREBROLYSIN; PLACEBO;

ACUTE DISEASE; ADULT; AGED; ARTICLE; ASIA; BARTHEL INDEX; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PHASE 4 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RANKIN SCALE; STANDARD; SYMPTOM; UNSPECIFIED SIDE EFFECT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AMINO ACIDS; ASIA; BRAIN ISCHEMIA; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEUROPROTECTIVE AGENTS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; YOUNG ADULT;

EID: 70349509056     PISSN: 17474930     EISSN: 17474949     Source Type: Journal    
DOI: 10.1111/j.1747-4949.2009.00340.x     Document Type: Article

References (23)

1. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ. Global and regional burden of disease and risk factors, 2001. 2006, 367:1747-1757.
2. Heiss WD. Experimental evidence of ischemic thresholds and functional recovery. 1992, 23:1668-1672.
3. Hossmann KA. Pathophysiology and therapy of experimental stroke. 2006, 26:1057-1083.
4. Tissue plasminogen activator for acute ischemic stroke. 1995, 333:1581-1587. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group.
5. Hacke W, Kaste M, Bluhmki E. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. 2008, 359:1317-1329. et al
6. O'Collins VE, Macleod MR, Donnan GA, Horky LL, van der Worp BH, Howells DW. 1,026 experimental treatments in acute stroke. 2006, 59:467-477.
7. Ovbiagele B, Kidwell CS, Starkman S, Saver JL. Potential role of neuroprotective agents in the treatment of patients with acute ischemic stroke. 2003, 5:367-375.
8. Ren JM, Sietsma D, Qiu S, Moessler H, Finklestein SP. Cerebrolysin enhances functional recovery following focal cerebral infarction in rats. 2007, 25:25-31.
9. Tatebayashi Y, Lee MH, Li L, Iqbal K, Grundke-Iqbal I. The dentate gyrus neurogenesis. 2003, 105:225-232.
10. Wronski R, Tompa P, Hutter-Paier B, Crailsheim K, Friedrich P, Windisch M. Inhibitory effect of a brain derived peptide preparation on the Ca++-dependent protease, calpain. 2000, 107:145-157.
11. Chen H, Tung YC, Li B, Iqbal K, Grundke-Iqbal I. Trophic factors counteract elevated FGF-2-induced inhibition of adult neurogenesis. 2007, 28:1148-1162.
12. Hong Z, Zhu G-X, Chen H-B. The clinical efficacy of Cerebrolysin in the treatment of acute ischemic stroke. 2005, 7:331-333. et al
13. Skvortsova VI, Shamalov NA, Stakhovskaya LV, Gubsky LV, Tikhonova IV, Smichkov AS. Cerebrolysin in acute ischemic stroke. 2005, 19((Suppl 2)):76. (Abstract)
14. Haffner Z, Javor L, Windisch M, Gmeinbauer R. Cerebrolysin in acute ischemic stroke. 1999, 5:52-53.
15. Volc D, Adler J. Therapeutic effects of Cerebrolysin with stroke patients during rehabilitation. 1998, 3-4:19-26.
16. Barolin GS, Koppi S, Kapeller E. Old and new aspects of stroke treatment with emphasis on metabolically active medication and rehabilitative outcome. 1996, 3:135-143.
17. Ladurner G, Kalvach P, Moessler H. Neuroprotective treatment with cerebrolysin in patients with acute stroke. 2005, 112:415-428.
18. Funke M, Fiehler J, Mewes I, Eiselt M, Rother I, Windisch M. Dose-dependent effects of Cerebrolysin on EEG and short-term memory of healthy volunteers during control and hyperventilation induced cerebral ischemia. 1998, 53((Suppl)):385-398.
19. Lehmacher W, Wassmer G, Reitmeir P. Procedures for two-sample comparisons with multiple endpoints controlling the experimentwise error rate. 1991, 47:511-521.
20. Tilley BC, Marler J, Geller NL. Use of a global test for multiple outcomes in stroke trials with application to the National Institute of Neurological Disorders and Stroke t-PA Stroke Trial. 1996, 27:2136-2142. et al
21. Wei LJ, Lachin JM. Two-sample asymptotically distribution-free tests for incomplete multi-variate observations. 1984, 79:653-661.
22. Thall PF, Lachin JM. Analysis of recurrent events. 1988, 83:339-347.
23. Lachin JM. Some large-sample distribution-free estimators and tests for multivariate partially incomplete data from two populations. 1992, 11:1151-1170.